ライフサイエンスコーパス: Enterobacter cloacae

1 er inoculation of their endophytic bacteria (Enterobacter cloacae).

2 hich is identical to plasmid pNDM-HF727 from Enterobacter cloacae.

3 gle D(H) gene segment (D-limited mice), with Enterobacter cloacae.

4 onse to alpha-1,3 dextran (DEX) expressed on Enterobacter cloacae.

5 ence analysis revealed that the organism was Enterobacter cloacae.

6 antibiotic for treatment of infections with Enterobacter cloacae.

7 robacter koseri but 97.0% similar to that of Enterobacter cloacae.

8 d by blood feeding, restored the immunity to Enterobacter cloacae.

9 illus, which most laboratories recognized as Enterobacter cloacae.

10 escens after injection of prepupae with live Enterobacter cloacae.

11 m patients were Pseudomonas aeruginosa (22), Enterobacter cloacae (21), Acinetobacter spp. (13), Ente

12 coli (18.8%), Klebsiella pneumoniae (14.2%), Enterobacter cloacae (9.1%), Acinetobacter spp. (6.2%),

13 hogens with interpretive criteria, excluding Enterobacter cloacae (98.3% S) and E. faecalis (86.0% S)

14 inst Escherichia coli, Klebsiella pneumonia, Enterobacter cloacae, Acinetobacter baumannii, and methi

15 linically important enzymes CTX-M-15, KPC-2, Enterobacter cloacae AmpC, Pseudomonas aeruginosa AmpC,

16 usly determined for the class C enzymes from Enterobacter cloacae and Citrobacter freundii.

17 rial cell wall biosynthetic enzyme MurA from Enterobacter cloacae and Escherichia coli in vitro.

18 A case of ventriculitis due to Enterobacter cloacae and Pseudomonas fulva following pla

19 microbial bacteremia, and seven of these had Enterobacter cloacae and S. marcescens in the same cultu

20 stant (IC(50), approximately 10,000 nM), and Enterobacter cloacae and Serratia marcescens were highly

21 348 Klebsiella pneumoniae, one (<1%) of 890 Enterobacter cloacae, and one (1%) of 162 Enterobacter a

22 d -negative strains), Klebsiella pneumoniae, Enterobacter cloacae, and Pseudomonas aeruginosa.

23 a: Escherichia coli, Pseudomonas aeruginosa, Enterobacter cloacae, and Yersinia enterocolitica.

24 L49 antibodies were chemically conjugated to Enterobacter cloacae beta-lactamase (bL), and their abil

25 nd the increasing clinical importance of the Enterobacter cloacae complex have often been discussed.

26 nt Escherichia coli, Enterobacter aerogenes, Enterobacter cloacae complex, Klebsiella pneumoniae, or

27 m Staphylococcus aureus, and aac(3)-VIa from Enterobacter cloacae (conferring resistance to kanamycin

28 oci from isolates of Serratia marcescens and Enterobacter cloacae, demonstrating the presence of in-f

29 y Citrobacter freundii, Clostridium species, Enterobacter cloacae, Enterococcus faecalis, Klebsiella

30 fied in the Enterobacteria Escherichia coli, Enterobacter cloacae, Erwinia herbicola, and Salmonella

31 ing probes for pathogenic bacteria including Enterobacter cloacae, Escherichia coli J96, Pseudomonas

32 isolates of important Gram-negative species-Enterobacter cloacae, Escherichia coli, Klebsiella pneum

33 The Enterobacter cloacae GC1 enzyme is an example of a class

34 The crystallographic structure of the Enterobacter cloacae GC1 extended-spectrum class C beta-

35 structure of the nitroreductase enzyme from Enterobacter cloacae has been determined for the oxidize

36 Enterobacter cloacae has been implicated as one of the c

37 Recently, enteric commensal bacteria Enterobacter cloacae has been recognized as a helper in

38 rganisms, intraocular infection secondary to Enterobacter cloacae infection is a devastating disease

39 Enterobacter cloacae is a clinically important Gram-nega

40 We describe an Enterobacter cloacae isolate harbouring a minor subpopul

41 iae isolates, 3 Escherichia coli isolates, 5 Enterobacter cloacae isolates, 2 S. marcescens isolates,

42 the x-ray structures of the D305A mutant of Enterobacter cloacae MurA and the D313A mutant of Escher

43 tured and depicted the Cys-115-PEP adduct of Enterobacter cloacae MurA in various reaction states by

44 ablished that Cys115 of Escherichia coli and Enterobacter cloacae MurA is the active site nucleophile

45 s been determined to be 8.3, by titration of Enterobacter cloacae MurA with the alkylating agent iodo

46 d the x-ray structure of the C115S mutant of Enterobacter cloacae MurA, which was crystallized in the

47 (n = 1,127), Escherichia coli (n = 149), and Enterobacter cloacae (n = 110).

48 ther Staphylococcus epidermidis (n = 100) or Enterobacter cloacae (n = 60).

49 1.9%), Escherichia coli (n = 129, 30.0%) and Enterobacter cloacae (n = 62, 14.4%) were the main Enter

50 ies of the flavin mononucleotide cofactor of Enterobacter cloacae nitroreductase (NR), determined und

51 The oxygen-insensitive nitroreductase from Enterobacter cloacae (NR) catalyzes two-electron reducti

52 A library of Enterobacter cloacae P99 beta-lactamase mutants was prod

53 ed reaction, cephalosporin hydrolysis by the Enterobacter cloacae P99 cephalosporinase (beta-lactam h

54 dase of Streptomyces sp. R61, a PBP, and the Enterobacter cloacae P99 cephalosporinase, a class C bet

55 inhibition of the class C beta-lactamase of Enterobacter cloacae P99 determined.

56 e) inactivates the class C beta-lactamase of Enterobacter cloacae P99 in a covalent fashion.

57 to react with the class C beta-lactamase of Enterobacter cloacae P99 in two ways, by acylation and b

58 stants for hydrolysis by beta-lactamase from Enterobacter cloacae P99 indicated kcat values of 476 +/

59 The class C beta-lactamase of Enterobacter cloacae P99 is closely similar in structure

60 The class C beta-lactamase of Enterobacter cloacae P99 is competitively inhibited by l

61 The class C serine beta-lactamase of Enterobacter cloacae P99 is irreversibly inhibited by O-

62 cts on V/K for the class C beta-lactamase of Enterobacter cloacae P99 suggest an acyl-transfer transi

63 The class C beta-lactamase of Enterobacter cloacae P99 was employed.

64 hibited typical class A (TEM-2) and class C (Enterobacter cloacae P99) beta-lactamases in a time-depe

65 , catalyzed by the class C beta-lactamase of Enterobacter cloacae P99, have been studied in order to

66 -2 antibody detected Escherichia coli CMY-2, Enterobacter cloacae P99, Klebsiella pneumoniae ACT-1, a

67 nactivators of the class C beta-lactamase of Enterobacter cloacae P99.

68 by class C beta-lactamases such as that from Enterobacter cloacae P99.

69 omyces R61 and the class C beta-lactamase of Enterobacter cloacae P99.

70 rally very similar class C beta-lactamase of Enterobacter cloacae P99.

71 several gram-negative bacteria, specifically Enterobacter cloacae, Pseudomonas aeruginosa, and Pantoe

72 LY]) and Enterobacter lignolyticus (formerly Enterobacter cloacae) SCF1 (enterolysin [ELY]).

73 , invasive aspergillosis (20%, 3 of 15), and Enterobacter cloacae, Serratia marcescens, Pneumocystis

74 mis, E. coli O157:H7, Klebsiella pneumoniae, Enterobacter cloacae, Shigella dysenteriae, Salmonella e

75 neage - accumulates LDs when challenged with Enterobacter cloacae, Sindbis, and Dengue viruses.

76 The membrane-bound selenate reductase of Enterobacter cloacae SLD1a-1 is purified in low yield an

77 erial species such as Klebsiella pneumoniae, Enterobacter cloacae, Stenotrophomonas maltophilia, and

78 Enterobacter cloacae strain G6809 with reduced susceptib

79 C beta-lactamase from a clinical isolate of Enterobacter cloacae strain GC1 with improved hydrolytic

80 fication of a Shiga toxin 1 (Stx1)-producing Enterobacter cloacae strain, M12X01451, from a human cli

81 nterobacter aerogenes and 13,954 isolates of Enterobacter cloacae tested using a Vitek system; for th

82 ing the melibiose-H(+) symporter (MelY) from Enterobacter cloacae that had enhanced fermentation on 1

83 t on four cases of endophthalmitis caused by Enterobacter cloacae: two in patients with acute postope

84 rates higher than the totals were noted with Enterobacter cloacae versus ampicillin-sulbactam, aztreo

85 e given 1 x 10(6) colony-forming units/mL of Enterobacter cloacae with the third feeding.